Telomere dynamics and genome stability in the human pancreatic tumor cell line MIAPaCa-2

Cytogenetic and Genome Research

Volumn 119, Issue 1-2, 2007, Pages 60-67

  Skrobot Vidacek N ^a   Cukusic A ^a   Ferenac Kis M ^a   Ivankovic M ^a   Jevtov, I ^a   Mrsic S ^b   Rubelj, I ^a  

^a RUDER BO KOVI INSTITUTE   (Croatia)

^b KBC Zagreb   (Croatia)

Author keywords

[No Author keywords available]

Indexed keywords

DNA POLYMERASE; GENOMIC DNA; PEPTIDE NUCLEIC ACID; TELOMERASE; THYMIDINE; TRITIUM;

AGAR GEL ELECTROPHORESIS; APOPTOSIS; ARTICLE; CELL SURVIVAL; CHROMATID; CHROMOSOME; CHROMOSOME ANALYSIS; CHROMOSOME G BAND; CYTOGENETICS; FIBROBLAST; FLUORESCENCE IN SITU HYBRIDIZATION; GENOMIC INSTABILITY; HUMAN; HUMAN CELL; KARYOTYPE; PANCREAS TUMOR; PRIORITY JOURNAL; SOUTHERN BLOTTING; TELOMERE; TUMOR CELL LINE; X CHROMOSOME;

APOPTOSIS; CELL LINE, TUMOR; CHROMOSOMES, HUMAN, X; GENOME, HUMAN; GENOMIC INSTABILITY; HUMANS; KARYOTYPING; PANCREATIC NEOPLASMS; TELOMERE;

EUKARYOTA;

EID: 37549050943     PISSN: 14248581     EISSN: None     Source Type: Journal    
DOI: 10.1159/000109620     Document Type: Article

References (51)

1. Allsopp RC, Vaziri H, Patterson C, Goldstein S, Younglai EV, et al: Telomere length predicts replicative capacity of human fibroblasts. Proc Natl Acad Sci USA 89:10114-10118 (1992).
2. Blackburn EH: Structure and function of telomeres. Nature 350:569-573 (1991).
3. Bodnar AG, Ouellette M, Frolkis M, Holt SE, Chiu CP, et al: Extension of life-span by introduction of telomerase into normal human cells. Science 279:349-352 (1998).
4. Bolzan AD, Bianchi MS: Telomeres, interstitial telomeric repeat sequences, and chromosomal aberrations. Mutat Res 612:189-214 (2006).
5. Cesare AJ, Griffith JD: Telomeric DNA in ALT cells is characterized by free telomeric circles and heterogeneous t-loops. Mol Cell Biol 24:9948-9957 (2004).
6. Chen C, Wu B, Wei T, Egholm M, Strauss WM: Unique chromosome identification and sequence-specific structural analysis with short PNA oligomers. Mamm Genome 11:384-391 (2000).
7. Counter CM, Hirte HW, Bacchetti S, Harley CB: Telomerase activity in human ovarian carcinoma. Proc Natl Acad Sci USA 91:2900-2904 (1994).
8. de Lange T: Protection of mammalian telomeres. Oncogene 21:532-540 (2002).
9. Dimri GP, Lee X, Basile G, Acosta M, Scott G, et al: A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci USA 92:9363-9367 (1995).
10. Dunham MA, Neumann AA, Fasching CL, Reddell RR: Telomere maintenance by recombination in human cells. Nat Genet 26:447-450 (2000).
11. Ferenac M, Polancec D, Huzak M, Pereira-Smith OM, Rubelj I: Early-senescing human skin fibroblasts do not demonstrate accelerated telomere shortening. J Gerontol A Biol Sci Med Sci 60:820-829 (2005).
12. Fouché N, Ozgur S, Roy D, Griffith JD: Replication fork regression in repetitive DNAs. Nucleic Acids Res 34:6044-6050 (2006).
13. Greider CW: Mammalian telomere dynamics: healing, fragmentation shortening and stabilization. Curr Opin Genet Dev 4:203-211 (1994).
14. Greider CW, Blackburn EH: Identification of a specific telomere terminal transferase activity in Tetrahymena extracts. Cell 43:405-413 (1985).
15. Griffith JD, Comeau L, Rosenfield S, Stansel RM, Bianchi A, et al: Mammalian telomeres end in a large duplex loop. Cell 97:503-514 (1999).
16. Harley CB: Telomere loss: mitotic clock or genetic time bomb? Mutat Res 256:271-282 (1991).
17. Harley CB, Futcher AB, Greider CW: Telomeres shorten during ageing of human fibroblasts. Nature 345:458-460 (1990).
18. Hastie ND, Dempster M, Dunlop MG, Thompson AM, Green DK, Allshire RC: Telomere reduction in human colorectal carcinoma and with ageing. Nature 346:866-868 (1990).
19. Herrmann M, Lorenz H-M, Voll R, Grunke M, Woith W, Kalden JR: A rapid and simple method for the isolation of apoptotic DNA fragments. Nucleic Acids Res 22:5506-5507 (1994).
20. ISCN 2005: An International System for Human Cytogenetic Nomenclature; Shaffer LG, Tommerup N (eds) (S. Karger, Basel 2005).
21. Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, et al: Specific association of human telomerase activity with immortal cells and cancer. Science 266:2011-2015 (1994).
22. Lansdorp PM: Major cutbacks at chromosome ends. Trends Biochem Sci 30:388-395 (2005).
23. Lansdorp PM, Verwoerd NP, van de Rijke FM, Dragowska V, Little MT, et al: Heterogeneity in telomere length of human chromosomes. Hum Mol Genet 5:685-691 (1996).
24. Lee JJ, Warburton D, Robertson EJ: Cytogenetic methods for the mouse: Preparation of chromosomes, karyotyping, and in situ hybridization. Anal Biochem 189:1-17 (1990).
25. Li D, Zhu J, Firozi PF, Abbruzzese JL, Evans DB, et al: Overexpression of oncogenic STK15/BTAK/Aurora A kinase in human pancreatic cancer. Clin Cancer Res 9:991-997 (2003).
26. Makarov VL, Hirose Y, Langmore JP: Long G tails at both ends of human chromosomes suggest a C strand degradation mechanism for telomere shortening. Cell 88:657-666 (1997).
27. Martens UM, Zijlmans JMJM, Poon SSS, Dragowska W, Yui J, et al: Short telomeres on human chromosome 17p. Nat Genet 18:76-80 (1998).
28. Neumann AA, Reddel RR: Telomere maintenance and cancer - look, no telomerase. Nat Rev Cancer 2:879-884 (2002).
29. Nilsson P, Mehle C, Remes K, Roos G: Telomerase activity in vivo in human malignant hematopoietic cells. Oncogene 9:3043-3048 (1994).
30. Okubo M, Tsurukubo Y, Higaki T, Kawabe T, Goto M, et al: Clonal chromosomal aberrations accompanied by strong telomerase activity in immortalization of human B-lymphoblastoid cell lines transformed by Epstein-Barr virus. Cancer Genet Cytogenet 129:30-34 (2001).
31. Olovnikov AM: Principle of marginotomy in template synthesis of polynucleotides. Dokl Akad Nauk SSSR 201:1496-1499 (1971).
32. Poon SS, Martens UM, Ward RK, Lansdorp PM: Telomere length measurements using digital fluorescence microscopy. Cytometry 36:267-278 (1999).
33. Rha SY, Izbicka E, Lawrence R, Davidson K, Sun D, et al: Effect of telomere and telomerase interactive agents on human tumor and normal cell lines. Clin Cancer Res 6:987-993 (2000).
34. Riethman H, Ambrosini A, Paul S: Human subtelomere structure and variation. Chromosome Res 13:505-515 (2005).
35. Rojanala S, Han H, Munoz RM, Vankayalapati H, Mahadevan D, et al: Aurora kinase-2 a potential molecular therapeutic target for pancreatic cancers. Proc Am Assoc Cancer Res 43:665 (2002).
36. Rubelj I, Vondracek Z: Stochastic mechanism of cellular aging - abrupt telomere shortening as a model for stochastic nature of cellular aging. J Theor Biol 197:425-438 (1999).
37. Sato N, Mizumoto K, Nishio S, Maehara N, Urashima T, et al: Up-regulation of telomerase activity in human pancreatic cancer cells after exposure to etoposide. Br J Cancer 82:1819-1826 (2000).
38. Seshadri T, Campisi J: Repression of c-fos transcription and an altered genetic program in senescent human fibroblasts. Science 247:205-209 (1990).
39. Shay JW, Bacchetti S: A survey of telomerase activity in human cancer. Eur J Cancer 33:787-791 (1997).
40. Slijepcevic P, Al-Wahiby S: Telomere biology: integrating chromosomal end protection with DNA damage response. Chromosoma 114:275-285 (2005).
41. Slijepcevic P, Bryant PE: Absence of terminal telomeric FISH signals in chromosomes from immortal Chinese hamster cells. Cytogenet Cell Genet 69:87-89 (1995).
42. Sprung CN, Afshar G, Chavez EA, Lansdorp P, Sabatier L, Murnane JP: Telomere instability in a human cancer cell line. Mutat Res 429:209-223 (1999).
43. Vaziri H, Schachter F, Uchida I, Wei L, Zhu X, et al: Loss of telomeric DNA during aging of normal and trisomy 21 human lymphocytes. Am J Hum Genet 52:661-667 (1993).
44. Vaziri H, Dragowska W, Allsopp RC, Thomas TE, Harley CB, Lansdorp PM: Evidence for a mitotic clock in human hematopoietic stem cells: loss of telomeric DNA with age. Proc Natl Acad Sci USA 91:9857-9860 (1994).
45. West SC: Enzymes and molecular mechanisms of genetic recombination. Annu Rev Biochem 61:603-640 (1992).
46. Wright WE, Piatyszek MA, Rainey WE, Byrd W, Shay JW: Telomerase activity in human germline and embryonic tissues and cells. Dev Genet 18:173-179 (1996).
47. Yajima T, Yagihashi A, Kameshima H, Kobayasji D, Hirata K, Watanabe N: Telomerase reverse transcriptase and telomeric-repeat binding factor protein 1 as regulators of telomerase activity in pancreatic cancer cells. Br J Cancer 85:752-757 (2001).
48. Yoshimura SH, Maruyama H, Ishikawa F, Ohki R, Takeyasu K: Molecular mechanisms of DNA end-loop formation by TRF2. Genes Cells 9:205-218 (2004).
49. Yunis AA, Arimura GK, Russin DJ: Human pancreatic carcinoma (MIAPaCa-2) in continuous culture: sensitivity to asparaginase. Int J Cancer 19:128-135 (1977).
50. Yunis JJ: High resolution of human chromosomes. Science 191:1268-1270 (1976).
51. Zahradka K, Slade D, Bailone A, Sommer S, Averbeck D, et al: Reassembly of shattered chromosomes in Deinococcus radiodurans. Nature 443:569-573 (2006).